Related references
Note: Only part of the references are listed.Clinical Management of Endometriosis
Tommaso Falcone et al.
OBSTETRICS AND GYNECOLOGY (2011)
Add-back therapy use and its impact on LA persistence in patients with endometriosis
Mahesh J. Fuldeore et al.
CURRENT MEDICAL RESEARCH AND OPINION (2010)
Do the dose or route of administration of norethisterone acetate as a part of hormone therapy play a role in risk of breast cancer: national-wide case-control study from Finland
Heli Lyytinen et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Estrogen Plus Progestin and Breast Cancer Incidence and Mortality in Postmenopausal Women
Rowan T. Chlebowski et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Use of Depot Medroxyprogesterone Acetate and Fracture Risk
Christian Meier et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Postmenopausal hormone therapy with estradiol and norethisterone acetate and mammographic density: findings from a cross-sectional study among Norwegian women
A. Stuedal et al.
CLIMACTERIC (2009)
Association between efficacy and body weight or body mass index for two low-dose oral contraceptives
Ronald T. Burkman et al.
CONTRACEPTION (2009)
Bone growth and turnover in progesterone receptor knockout mice
David J. Rickard et al.
ENDOCRINOLOGY (2008)
Phase III Randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest oncology group study 9626
J. Wendall Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Gonadotropin-releasing hormone agonists for endometriosis
David L. Olive
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Long-term effects of progestins on bone quality and fractures
Jos H. H. Thijssen
GYNECOLOGICAL ENDOCRINOLOGY (2007)
Formation of ethinyl estradiol in women during treatment with norethindrone acetate
Micheline C. Chu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause
Jacques E. Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
The role of progestins in treating the pain of endometriosis
Eric S. Surrey
JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY (2006)
Bone mineral density and depot medroxyprogesterone acetate
Paola Albertazzi et al.
CONTRACEPTION (2006)
Advances in the management of endometriosis: an update for clinicians
P Crosignani et al.
HUMAN REPRODUCTION UPDATE (2006)
Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain
PG Crosignani et al.
HUMAN REPRODUCTION (2006)
Tibolone: Clinical recommendations and practical guidelines - A report of the International Tibolone Consensus Group
P Kenemans et al.
MATURITAS (2005)
Selective progesterone receptor modulator development and use in the treatment of leiomyomata and endometriosis
K Chwalisz et al.
ENDOCRINE REVIEWS (2005)
Mechanisms of sex steroids - Future developments
H Kuhl
MATURITAS (2004)
Different cerebrovascular effects of medroxyprogesterone acetate and norethisterone acetate in the New Zealand White rabbit
SH Pedersen et al.
CLIMACTERIC (2004)
Coregulator function: A key to understanding tissue specificity of selective receptor modulators
CL Smith et al.
ENDOCRINE REVIEWS (2004)
Progestogen therapies: differences in clinical effects?
I Wiegratz et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2004)
Prolonged use of gonadotropin-releasing hormone agonist and tibolone as add-back therapy for the treatment of endometrial hyperplasia
T Agorastos et al.
MATURITAS (2004)
One year comparison between two add-back therapies in patients treated with a GnRH agonist for symptomatic endometriosis:: a randomized double-blind trial
H Fernandez et al.
HUMAN REPRODUCTION (2004)
Mammographic breast density, hormones, and growth factors during continuous combined hormone therapy
P Conner et al.
FERTILITY AND STERILITY (2004)
Classification and pharmacology of progestins
AE Schindler et al.
MATURITAS (2003)
Steroid receptors and proliferation in the human breast
RB Clarke
STEROIDS (2003)
Breast cancer and hormone-replacement therapy in the Million Women Study
E Banks et al.
LANCET (2003)
Suppressive function of androgen receptor in bone resorption
H Kawano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Consensus statement for the management of chronic pelvic pain and endometriosis: proceedings of an expert-panel consensus process
JC Gambone et al.
FERTILITY AND STERILITY (2002)
Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women
G Wells et al.
ENDOCRINE REVIEWS (2002)
Risks and benefits of estrogen plus progestin in healthy postmenopausal women - Principal results from the Women's Health Initiative randomized controlled trial
JE Rossouw et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
Nongenomic vasodilator action of progesterone on primate coronary arteries
RD Minshall et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Sex steroids used in hormonal treatment increase vascular procoagulant activity by inducing thrombin receptor (PAR-1) expression - Role of the glucocorticoid receptor
O Herkert et al.
CIRCULATION (2001)
Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate
WH Utian et al.
FERTILITY AND STERILITY (2001)
Effects of postmenopausal hormone replacement therapy on lipid, lipoprotein, and apolipoprotein (a) concentrations: analysis of studies published from 1974-2000
IF Godsland
FERTILITY AND STERILITY (2001)
Immunogenicity and protective efficacy of oligomeric human immunodeficiency virus type 1 gp140
PL Earl et al.
JOURNAL OF VIROLOGY (2001)
Natural progesterone, but not medroxyprogesterone acetate, enhances the beneficial effect of estrogen on exercise-induced myocardial ischemia in postmenopausal women
GMC Rosano et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
